The risk facing the UK from cyber threats is being widely underestimated, according to the head of the National Cyber Security Centre. This warning will be emphasized in their first major speech, highlighting the importance of recognizing and addressing these risks to national security.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
